PHASE I – SMALL MOLECULE LEADING THERAPIES PIPELINE

Tillat Manufactures Leading Medications in the World, in a Halal-Compliant Manner. Expected in Market by 2H24.

PHASE I – BIOTHERAPEUTIC LEADING THERAPIES PIPELINE

Tillat Manufactures Leading Medications in the World, in a Halal-Compliant Manner. Expected in Market by 1H25